Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 9,284
Sort by:

Angina Pectoris Drugs - Global Market Outlook (2017-2023)

US$ 4,150.00

According to Stratistics MRC, the Global Angina Pectoris Drugs Market is accounted for $8501.3 million in 2016 and expected to grow at ... diseases and developing healthcare infrastructure. The key players in global Angina Pectoris Drugs market are Astellas Pharma, Cardium Therapeutics, Cardeus Pharmaceuticals, ...

August 2017 138 pages

Global Gummy Vitamin Market Rport 2017

US$ 2,350.00

... still maintained a relatively optimistic growth, the past four years, Gummy Vitamin market size to maintain the average annual growth rate of 4.27% from ... the next few years, Gummy Vitamin market size will be further expanded, we expect that by 2021, The market size of the Gummy Vitamin will reach 2240 million ...

July 2017 134 pages

European ICU Sedation Drugs Market: Size, Trends & Forecasts (2017-2021)

US$ 800.00

... analysis of Europe ICU sedation drugs market, with detailed analysis of market size and growth, and segmentation of the industry. The analysis of the European ICU sedation drugs market includes the market by value ...

July 2017 56 pages

ASIA-PACIFIC IBS-C DRUG MARKET FORECAST 2017-2025

US$ 1,250.00

KEY FINDING The Asia-Pacific IBS-c drug market is predicted to grow at a CAGR of 6.29% over the forecast period of 2017-2025 and generate an estimated revenue of 210.28 ... habits and the pipeline drugs in the market are some of the major drivers for the Asian IBS-c drug market. The market is segmented according ...

July 2017 58 pages

ASIA-PACIFIC OPIOID INDUCED CONSTIPATION DRUG MARKET FORECAST 2017-2025

US$ 1,250.00

KEY FINDINGS The Asia-Pacific Opioid Constipation Drug market is estimated to grow at a CAGR of ... and methyl naltrexone bromide and some pipeline drugs such as naldemedine, alvimopan, dolcanatide and ... branded prescribed drugs and over the counter drugs. A large number of considerations while using opioids is a ...

July 2017 54 pages

EUROPE IBS-C DRUG MARKET FORECAST 2017-2025

US$ 1,250.00

KEY FINDINGS The Europe IBS-c drug market is expected to grow at a CAGR of 5.29% over the forecast period of 2017-2025. The market was valued at $468.6 million in the year 2016 ...

July 2017 54 pages

EUROPE OPIOID INDUCED CONSTIPATION DRUG MARKET FORECAST 2017-2025

US$ 1,250.00

KEY FINDINGS The Europe opioid constipation drug market is expected to grow at a CAGR of 4.00% during the forecast period ... to $1273.34 million by 2025. MARKET INSIGHTS The Europe opioid constipation drug market is mainly driven by the increasing opioids prescription in the region. The market can be segmented ...

July 2017 52 pages

GLOBAL ANTI-DEPRESSANT DRUGS, DEVICES, AND THERAPIES MARKET FORECAST 2017-2025

US$ 2,500.00

KEY FINDINGS The Global Anti-depressant drugs, devices, and therapies market is anticipated to grow at a CAGR of 2.12% over the ... promise during the forecasted years. REGIONAL INSIGHTS Geographically, the global anti-depressant drugs, devices, and therapies market is segmented into: North America - U.S. & ...

July 2017 145 pages

GLOBAL IBS-C DRUG MARKET FORECAST 2017-2025

US$ 2,500.00

... Of these, the North America region is anticipated to dominate the global IBS-C drug market over the forecast period on account of its highly developed healthcare systems and ...

July 2017 112 pages

GLOBAL OPIOID INDUCED CONSTIPATION DRUG MARKET FORECAST 2017-2025

US$ 2,500.00

... MARKET INSIGHTS The global Opioid Induced Constipation (OIC) drug market segments include drug type and prescription type. Drug types are further ... strategy adopted by the various market players of global Opioid Induced Constipation (OIC) drug market.The AstraZeneca Pharmaceuticals’s Movantik developed a ...

July 2017 113 pages

NORTH AMERICA IBS-C DRUG MARKET FORECAST 2017-2025

US$ 1,250.00

KEY FACTORS The North American IBS-c drug market was valued at $439.5 million in 2016. The market is expected to grow at a CAGR of 7.30% and generate $825.07 million by 2025. The ...

July 2017 55 pages

NORTH AMERICA OPIOID INDUCED CONSTIPATION DRUG MARKET FORECAST 2017-2025

US$ 1,250.00

KEY FINDINGS The North America opioid induced constipation drug market is expected to be the fastest growing market during the ... in 2016 and reach $1382.73 million by 2025. MARKET INSIGHTS The North American OIC drug market is segmented on the basis of the type ...

July 2017 51 pages

Payer attitudes to Orphan Drug pricing

US$ 2,245.00

Payer Attitudes to Orphan Drug Funding The explosion of orphan drugs across Europe and the US is pushing healthcare finances towards breaking point according to payers. Requests for orphan drug designation have reached ...

July 2017 -

ASIA-PACIFIC CHRONIC IDIOPATHIC CONSTIPATION DRUG MARKET FORECAST 2017-2025

US$ 1,250.00

KEY FINDINGS The Asia-Pacific chronic idiopathic constipation drug market is anticipated grow at a CAGR of 5.76% during the forecast period ... by the type of drug and by the type of prescription. The drug lubiprostone is dominating the drug segment closely followed by the drug linaclotide. By prescription type ...

July 2017 62 pages

Global Alzheimer’s Disease Drugs Market, Regional Analysis & Forecast, Major Deals & Funding, and Pipeline Drugs Analysis to 2021

US$ 1,250.00

... . Global Alzheimer’s Disease Drugs Market and Pipeline Drugs Analysis In 2016, the global market for Alzheimer’s disease drugs was dominated by Namenda, Memary, Aricept and Exelon. The combined market share of these four drugs ... largest market. Japan is the second leading market for Alzheimer’s disease drugs market accounting for XXX% market share in 2016. China stands at the third spot in the global Alzheimer’s disease drugs market being ...

July 2017 189 pages

Global Peptide Antibiotics Market & Clinical Pipeline Insight 2023

US$ 2,000.00

... . “Global Peptide Antibiotics Market & Clinical Pipeline Insight 2023” report gives comprehensive insight on clinical and non-clinical parameters involved in the development and commercialization of global peptide antibiotics market. As per report findings, peptide antibiotics are ...

July 2017 140 pages

Chronic Kidney Disease (CKD) Drugs - Global Market Outlook (2017-2023)

US$ 4,150.00

According to Stratistics MRC, the Global Chronic Kidney Disease (CKD) Drugs market is expected to grow from $12.87 billion in 2016 to reach $16.13 billion by ... that are shaping the global market include, growing incidences of chronic kidney diseases, rise in aged population, rising incidence of diabetes and ...

June 2017 160 pages

Antibody Drug Conjugates: Technologies and Global Markets

US$ 2,500.00

Build your market intelligence strategies with our antibody drug conjugates market report insightful analysis and five year CAGRs by segment.

June 2017 132 pages

Global Antibody Drugs Industry Market Research Report

US$ 2,960.00

... characteristics of the Antibody Drugs market. The Antibody Drugs market can be split based on product types, major applications, and important regions. Major Players in Antibody Drugs market are: Spectrum Pharmaceuticals ... types of Antibody Drugs products covered in this report are: Fully human antibodies Humanized antibody Murine Chimeric antibodies Most widely used downstream fields of Antibody Drugs market covered in this ...

June 2017 158 pages

Global Depression Drugs Industry Market Research Report

US$ 2,960.00

... Depression Drugs industrial chain, this report mainly elaborate the definition, types, applications and major players of Depression Drugs market in details. Deep analysis about market status ... characteristics of the Depression Drugs market. The Depression Drugs market can be split based on product types, major applications, and important regions. Major Players in Depression Drugs market are: Cadista Pfizer ...

June 2017 134 pages

Global Hepatitis Drugs Industry Market Research Report

US$ 2,960.00

... Hepatitis Drugs industrial chain, this report mainly elaborate the definition, types, applications and major players of Hepatitis Drugs market in details. Deep analysis about market status ... characteristics of the Hepatitis Drugs market. The Hepatitis Drugs market can be split based on product types, major applications, and important regions. Major Players in Hepatitis Drugs market are: Vertex Pharmaceuticals ...

June 2017 171 pages

Global Immunosuppressant Drugs Industry Market Research Report

US$ 2,960.00

... Immunosuppressant Drugs industrial chain, this report mainly elaborate the definition, types, applications and major players of Immunosuppressant Drugs market in details. Deep analysis about market status ... characteristics of the Immunosuppressant Drugs market. The Immunosuppressant Drugs market can be split based on product types, major applications, and important regions. Major Players in Immunosuppressant Drugs market are: Veloxis Pharmaceuticals ...

June 2017 150 pages

Global Tinnitus Drug Industry Market Research Report

US$ 2,960.00

... characteristics of the Tinnitus Drug market. The Tinnitus Drug market can be split based on product types, major applications, and important regions. Major Players in Tinnitus Drug market are: Actavis Sandoz Teva Mallinckrodt Mylan Sun Pharmaceutical Taro Pharmaceutical Pfizer Major Regions play vital role in Tinnitus Drug market are ...

June 2017 157 pages

United States Anesthesia Drugs Market & Forecast

US$ 1,800.00

... Methohexital Sodium, Pentobarbital, Etomidate and Fentanyl are commonly used general intravenous anesthesia in the United States. Among these anesthesia, Propofol and Benzodiazepines Class are the leading anesthesia drugs ...

June 2017 -

EUROPE OPHTHALMIC DRUGS & DEVICES MARKET FORECAST 2017-2025

US$ 1,250.00

KEY FINDINGS Europe ophthalmic drugs & devices market was valued at $15026.32 million in 2016 and is ... dominance of refractive errors. MARKET INSIGHTS The Asia-Pacific ophthalmic drugs & devices market is segmented by ophthalmic devices, surgery devices, vision care, by type of diseases, by therapeutics ...

June 2017 79 pages

GLOBAL OPHTHALMIC DRUGS & DEVICES MARKET FORECAST 2017-2025

US$ 2,500.00

KEY FINDINGS The global ophthalmic drugs market is estimated to grow at an approximate CAGR of 7.86% during the period of 2017 ... the largest market share in the global ophthalmic drugs market. Europe accounts for a second largest market share in the global ophthalmic drugs market. Asia-Pacific is estimated ...

June 2017 148 pages

NORTH AMERICA OPHTHALMIC DRUGS & DEVICES MARKET FORECAST 2017-2025

US$ 1,250.00

... to the high dominance of refractive errors. MARKET INSIGHTS The North America ophthalmic drugs & devices market is segmented by ophthalmic devices, surgery devices, vision care, by type of diseases ...

June 2017 74 pages

Asia-Pacific Paracetamol Market by Manufacturers, Regions, Type and Application, Forecast to 2022

US$ 4,480.00

... the Asia-Pacific Paracetamol market. Chapter 1, to describe Paracetamol Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Paracetamol ...

June 2017 116 pages

Global Injectable Drug Market (2017-2021 Edition)

US$ 700.00

... “Global Injectable Drug Market (2017-2021 Edition)” provides an in-depth analysis of the global injectable market with detailed analysis of the actual and the expected market size along with the market size of each market segment. Growth of the overall global injectable drug market has been forecasted for the period 2017-2021, taking ...

June 2017 35 pages

Global Orphan Drugs Market- Industry Analysis & Outlook (2017-2021)

US$ 800.00

... improving healthcare facilities. The global orphan drugs market is expected to grow in future due to prolonged orphan drug market exclusivity, increasing sales of prescription drugs, attractive orphan drug policies, rising healthcare expenditure ...

May 2017 67 pages

Vitamin D Testing - Global Market Outlook (2017-2023)

US$ 4,150.00

According to Stratistics MRC, the Global Vitamin D Testing Market is expected to grow at a CAGR of 6.2% during the forecast period. ... region. Some of the key players in Vitamin D Testing market include F. Hoffmann-La Roche Ltd., Abbott Diagnostics, Vitamin D Company, Siemens Healthcare Diagnostics, Biomeriux ...

May 2017 158 pages

ASIA-PACIFIC OPHTHALMIC DRUGS & DEVICES MARKET FORECAST 2017-2025

US$ 1,250.00

KEY FINDINGS Asia Pacific ophthalmic drugs & devices market was valued at $11815.02 million in 2016 and ... the high dominance of refractive errors. MARKET INSIGHTS The Asia-Pacific ophthalmic drugs & devices market is segmented by ophthalmic devices, surgery devices, vision care, by type of diseases, by ...

May 2017 78 pages

Global Ophthalmic Drugs Market Forecast 2017-2024

US$ 2,500.00

... North America ophthalmic drugs & devices market holds high growth prospects in the near futureHowever, over the forecasted period Asia- ... , this market is dominated by global players like Alex and Topcon Corporation.Global ophthalmic drugs market has a large number of market players but, the market is dominated ...

May 2017 172 pages

Vitamin D Testing Market Analysis By Type of Test (25-Hydroxy Vitamin D Tests; 1, 25-Dihydroxy Vitamin D Tests), Region (North America, Europe, Asia Pacific, South & Central America, MEA), And Segment Forecasts, 2014 - 2025

US$ 5,950.00

The global vitamin D testing market is expected to reach USD 1.1 billion by 2025, according to a new report by ... level of vitamin D in two forms. Hence, the market has been divided by two major types of tests, namely 25-Hydroxy Vitamin D test and 1, 25-Dihydroxy vitamin test. The 5-hydroxy vitamin D tests or ...

May 2017 100 pages

Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)

US$ 2,000.00

... backing the growth of Global Influenza Market. According to Azoth Analytics research report, “Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis ...

May 2017 164 pages

Drug Testing: Technologies and Global Markets

US$ 2,500.00

The global drug of abuse (DOA) testing market reached nearly $3.0 billion in 2016. This market is estimated to grow at a compound annual growth rate ( ... 2022 from $3.1 billion in 2017. Urine DOA testing, the largest segment of the market, reached $1.7 billion in 2016. This market is estimated to grow at a CAGR ...

May 2017 135 pages

North America Head Lice Infestation Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022

US$ 4,480.00

... is head to head contact. Lice are human parasites that feed on the blood of the infested person. SCOPE OF THE REPORT: This report focuses on the Head Lice Infestation Drug in North America ... Adult There are 15 Chapters to deeply display the North America Head Lice Infestation Drug market. Chapter 1, to describe Head Lice Infestation Drug Introduction, product type and application, market ...

May 2017 117 pages

Global Head Lice Infestation Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022

US$ 3,480.00

... is head to head contact. Lice are human parasites that feed on the blood of the infested person. SCOPE OF THE REPORT: This report focuses on the Head Lice Infestation Drug in Global market ... Adult There are 15 Chapters to deeply display the global Head Lice Infestation Drug market. Chapter 1, to describe Head Lice Infestation Drug Introduction, product scope, market overview, market opportunities, market ...

May 2017 117 pages

North America Dental Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022

US$ 4,480.00

... North America Dental Drug market. Chapter 1, to describe Dental Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Dental Drug ...

May 2017 121 pages

North America Probiotics Market by Manufacturers, Countries, Type and Application, Forecast to 2022

US$ 4,480.00

... Other Market Segment by Applications, can be divided into Food & Beverage Drugs Dietary Supplements Others There are 15 Chapters to deeply display the North America Probiotics market. Chapter 1, to describe Probiotics Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Probiotics ...

May 2017 117 pages

Global Dental Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022

US$ 3,480.00

... Hospitals Dental Clinics Drugstores There are 15 Chapters to deeply display the global Dental Drug market. Chapter 1, to describe Dental Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Dental Drug, with ...

May 2017 121 pages

Global Duchenne Muscular Dystrophy Therapeutics Market By Drug (Translarna, Emflaza, EXONDYS 51), By Therapeutic Approach (Steroid Therapy, Exon Skipping, Mutation Suppression) Clinical Trial Assessment & Pipeline Analysis (By Phase, Geography, and Key Player) Outlook 2022

US$ 2,500.00

... market. According to RNCOS’ new research report “Global Duchenne Muscular Dystrophy Therapeutics Market By Drug (Translarna, Emflaza, EXONDYS 51), By Therapeutic Approach (Steroid Therapy, Exon Skipping, Mutation Suppression ... position of Europe in the Duchenne Muscular Dystrophy market. The later part of the report discusses some of the prominent players in the global Duchenne Muscular Dystrophy Therapeutics market. The market ...

May 2017 100 pages

Global Hemophilia Therapeutics Market By Drug (Advate, NovoSeven, Kogenate/Kovaltry, Feiba), By Type of Hemophilia (Hemophilia A, Hemophilia B), By Treatment (On-Demand, Prophylaxis), By Therapy (Replacement Therapy, Immune Tolerance Induction Therapy) Outlook 2022

US$ 2,500.00

... growth of the global hemophilia therapeutics market. The global hemophilia therapeutics market has been segmented on the basis of type of hemophilia, i.e. Hemophilia A, Hemophilia B, and Others. Hemophilia A occupies the largest share in the global hemophilia therapeutics market, owing to the ...

May 2017 95 pages

Global Peptide Therapeutics Market & Clinical Trials Insight 2022

US$ 3,000.00

... Therapeutics Peptide Therapeutics by Applications & Indications Peptides Clinical Trials Insight by Phase, Indication & Company Insight on 688 Peptide Drugs in Clinical Trials Clinical & Patent Insight on 119 Marketed Peptides Future Peptide Therapeutics Market Outlook “Global Peptide Therapeutics Market ...

May 2017 1300 pages

Global Intravenous (IV) Iron Drugs Market: Industry Analysis & Outlook (2017-2021)

US$ 800.00

... body. The report “Global I.V. Iron Drugs Market” provides a comprehensive study of iron product market and I.V. iron market globally. It also provides ... industry are paradigm shift from oral iron drugs to intravenous iron drugs and introduction of first generation drugs InFeD and Dexeferrum. However, the ...

April 2017 64 pages

ASIA PACIFIC DRUG DISCOVERY MARKET FORECAST 2017-2024

US$ 1,950.00

... , Australia and rest of Asia Pacific. The entry of new companies in the market and substitute products acts as a threat to the Asia pacific drug discovery market. Discovery of new drugs being delayed due ...

April 2017 61 pages

EUROPE DRUG DISCOVERY MARKET FORECAST 2017-2024

US$ 1,950.00

... Europe drug discovery market are UK, France, Germany, Spain, Italy and rest of Europe. The entry of new companies in the market and substitute products poses a threat to the Europe drug discovery market. Discovery ...

April 2017 67 pages

NORTH AMERICA DRUG DISCOVERY MARKET FORECAST 2017-2024

US$ 1,950.00

KEY FINDINGS The North America drug discovery market in 2016 was worth $13244 million. The market is expected to reach $26134 million by 2024 at a CAGR of 8.9% between 2016 and ...

April 2017 75 pages

Global Double Barreled Antibodies Drug Sales (BLINCYTO & Removab), Pipeline Analysis (By Phase, Technology, and Indication), & Global Market Forecasts 2022

US$ 2,500.00

... resulting bi-specific antibody has binding affinities for two or three different epitopes concomitantly. According to the RNCOS report entitled “Global Double Barreled Antibodies Drug Sales (BLINCYTO & Removab), Pipeline Analysis (By Phase, Technology, and Indication), & Global Market Forecasts 2022”, the double barreled antibodies market is anticipated ...

April 2017 80 pages

Global Hepatocellular Carcinoma Drug Sales (Nexavar & Miripla), Pipeline Analysis and Global Market Forecast 2022

US$ 2,500.00

... , or NASH. As per RNCOS report “Global Hepatocellular Carcinoma Drug Sales (Nexavar & Miripla), Pipeline Analysis and Global Market Forecast 2022” the global hepatocellular carcinoma drug market is anticipated to witness a remarkable growth ... acquisitions taking place in the global hepatocellular carcinoma drug market. The last section of the report discusses about the prominent players in global hepatocellular carcinoma drug market. A brief business ...

April 2017 70 pages

Filters

Search

Publishers

1
318
174
29
4
667
409
35
27
971
77
19
16
425
2
21
1
16
111
1
5
9
2,264
5
4
31
6
142
1
17
15
248
651
89
1
373
26
34
586
1
2
16
6
4
84
36
3
4
2
7
15
53
16
26
83
11
32
8
2
17
102
28
19
4
7
3
324
15
1
23
68
24
29
44
296
17
18
2

Regions

131
40
38
37
37
35
32
21
10
10
9
9
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
5
5
5
5
4
4
3
3
3
3
3
89
12
354
31
6
6
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
37
4
4
3
3
3
1
1
3
9
7,948

Price

Date

Pages

Offers

9
1